Lawsuit loans add new risk for the injured

By Binyamin Appelbaum and Ben Hallman

The business of lending to plaintiffs has blossomed over the past decade, part of a growing trend in which banks and hedge funds seeking unt

Excerpts from this story referencing "Vioxx":

"… turn.” …"

"… y to Larry Long. The drug's maker, Merck, already had agreed to settle the Vioxx class action. The projected payouts were relatively easy to calculate: Lon …"

"… ge of people that are in need.” Oasis made loans on similar terms to 43 Vioxx plaintiffs, totaling about $224,000. Orran L. Brown, the Virginia lawyer …"

"… Gary Chodes, the company’s chief executive, said the performance of the Vioxx loans showed why Oasis must charge high rates. Eight of the 43 borrowers f …"

Did the FDA miss signals on a troubled heart drug?

By Jeanne Lenzer

It has been a rough eight months for the drug maker Actavis, Inc. and its powerful heart drug, Digitek. Following repeated Food and Drug Adm

Excerpts from this story referencing "Vioxx":

"… s to journalists and holds a news conference. In 2004, when the painkiller Vioxx was found to cause heart attacks, the agency not only issued its own news …"

Painkiller trial raises questions for FDA, Pfizer

By Shannon Brownlee and Jeanne Lenzer

In February 2005, the U.S. Food and Drug Administration (FDA) called a three-day hearing to review the risks of three painkillers known as C

Excerpts from this story referencing "Vioxx":

"… an FDA advisory panel -- was beset by controversy. One of the COX-2 drugs, Vioxx, had recently been withdrawn from the market for safety reasons. The FDA h …"

"… e were published reports of suppressed drug safety data regarding not just Vioxx, but another COX-2 inhibitor, Celebrex. Emotions were running high as the …"

"… ainkillers.The previous September, pharmaceutical firm Merck had withdrawn Vioxx voluntarily, shortly before evidence surfaced to suggest that the drug cau …"

"… sometime FDA critic well-known for his early warning about the dangers of Vioxx, is the principal investigator on the study known as PRECISION (the Prospe …"

Advertisement

FDA staff travels on drug industry dollars

By Alexander Cohen

Groups tied to FDA-regulated industry paying for agency officials' trips

Excerpts from this story referencing "Vioxx":

"… taken by employees of the FDA.The FDA has come under heavy criticism since Vioxx and other widely prescribed drugs were recalled for safety reasons. Member …"

"… ew Drug Safety Oversight Board.  After the recall pileup of Vioxx and other potentially dangerous medications, the safety board was establis …"

FDA: A shell of its former self

By M. Asif Ismail

The Food and Drug Administration lacks the power to regulate pharmaceuticals and keep you safe

Excerpts from this story referencing "Vioxx":

"… as COX-2 inhibitors, were found to cause severe side effects. Merck's Vioxx and Pfizer's Bextra were withdrawn from the market. Celebrex was kept on t …"

"… strongest safety alert.David Graham, an FDA whistleblower, estimated that Vioxx may have caused heart attacks in as many as 140,000 Americans and led to a …"

"… nd led to as many as 55,000 deaths in the United States.In the wake of the Vioxx controversy, news organizations documented the inadequacy of the safety mo …"

"… e safety monitoring system as well as the FDA's inaction. Complaints about Vioxx, media stories revealed, had been trickling in since 2001."The fact is tha …"

Drug industry influence timeline

What the pharmaceutical industry has gotten on its political investment

Excerpts from this story referencing "Vioxx":

"… The move comes amidst heavily publicized safety concerns from painkillers Vioxx and Bextra, both of which were removed from the market in 2005.2005The pha …"

Advertisement

FDA failure to ensure drug safety

By The Center for Public Integrity

Vioxx dangers raise questions about FDA's ability to monitor drugs

Excerpts from this story referencing "Vioxx":

"… lure: its lack of action against the popular arthritis and pain medication Vioxx despite clear and convincing evidence that the drug posed a threat to thou …"

"… own. In September 2004 the pharmaceutical giant Merck voluntarily withdrew Vioxx after it became evident that the drug increased the risk of cardiovascular …"

"… s currently configured, is incapable of protecting America against another Vioxx. We are virtually defenseless.” The incident raised troubling questions …"

"… hen its ability to monitor drug performance and could help prevent another Vioxx-like debacle. …"